Disparities in First-line Treatment Initiation Among US Medicare Beneficiaries with Myelodysplastic Syndromes (MDS)

Christopher R. Cogle,Sheila R. Reddy,Eunice Chang,Sohum Gokhale,Michael S. Broder,Michael McGuire

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2018）

引用 0|浏览6

暂无评分

摘要

To measure contemporary use of first-line therapy for MDS, which can reduce the need for blood transfusions, and to determine patient/disease characteristics associated with first-line treatment initiation.

查看译文

关键词

myelodysplastic syndromes,lenalidomide,azacitidine,decitabine,health outcomes research

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要